CellTribune.com: Cell and Gene Therapy News Updates

U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01 Study

Cell Tribune - July 11, 2020

0

New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing antibiotic pipeline...

Cell Tribune - July 9, 2020

0

Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory...

Cell Tribune - February 7, 2020

0

Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to...

Cell Tribune - November 4, 2019

0

Mogrify Raises Additional $16 Million to Advance its Mission to Transform the Development...

Cell Tribune - October 14, 2019

0

BUSINESS

All

Business

U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...

Cell Tribune - July 11, 2020 0

Cellectis a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has...

New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing...

July 9, 2020

Sonoma Biotherapeutics launches with $40 million in Series A funding to...

February 7, 2020

Tmunity and Oncora Medical Partner to Advance the Use of Real-World...

November 4, 2019

Sigilon Therapeutics approaches the clinic

October 23, 2019

MEDICAL DEVICES

All

Intarcia Therapeutics Secures Additional $206M Financing; Gates Foundation to Invest up to $140M in Grants and Equity

Cell Tribune - December 30, 2016

Bionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia

Cell Tribune - December 21, 2016

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy

September 17, 2018

MANUFACTURING

Cell Therapy

Servier Appoints MaSTherCell For The Development Of Its CAR-T Cell Therapy...

Cell Tribune - January 24, 2017 0

GERMANTOWN, MD--(Marketwired - January 20, 2017) - Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its...

DON'T MISS

ViaCyte Presented Preliminary PEC-Direct Clinical Data at Cell & Gene Meeting on the Mesa

Cell Tribune - October 5, 2019

Pluristem and New York Blood Center to Collaborate in Evaluating PLX-R18 as an Adjuvant...

Cell Tribune - December 27, 2016

Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis...

Cell Tribune - January 29, 2018

Program Manager, UW Advanced Cellular Therapy

Cell Tribune - January 28, 2017

JOURNAL SPOTLIGHT

‘Decorated’ Stem Cells Could Offer Targeted Heart Repair

Cell Tribune - January 10, 2018 0

Cell Therapy

Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury – and...

NEW PRODUCTS

CAR-T cell therapy benefits limited to few patients because of ‘Insurance...

January 11, 2018

Helix BioPharma Corp. announces the signing of a non-binding letter of...

December 23, 2016

EVEN MORE NEWS

Intarcia Therapeutics Secures Additional $206M Financing; Gates Foundation to Invest up to $140M in Grants and Equity

Cell Tribune - December 30, 2016

Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis Bullosa

Cell Tribune - January 29, 2018

FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase III Study

Cell Tribune - January 9, 2018

LATEST ARTICLES

Business

Tmunity and Oncora Medical Partner to Advance the Use of Real-World...

Cell Tribune - November 4, 2019 0

Business

Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research

Cell Tribune - October 14, 2019 0

Business

Wuxi AppTec to expand facilities and operations to support cell and...

Cell Tribune - January 1, 2019 0

Business

U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...

Cell Tribune - July 11, 2020 0

Business

New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing...

Cell Tribune - July 9, 2020 0

Business

Sonoma Biotherapeutics launches with $40 million in Series A funding to...

Cell Tribune - February 7, 2020 0

Cell Therapy

Sigilon Therapeutics approaches the clinic

Cell Tribune - October 23, 2019 0

Health

National Academy of Medicine Launches Global Competition Seeking Solutions for Improving...

Cell Tribune - October 23, 2019 0

Clinical Trials

University of Minnesota opens first-ever US clinical trial of engineered iPSC-derived...

Cell Tribune - October 21, 2019 0

Business

MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy...

Cell Tribune - October 21, 2019 0

Cell Therapy

ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology...

Cell Tribune - October 14, 2019 0

Business

Mogrify Raises Additional $16 Million to Advance its Mission to Transform...

Cell Tribune - October 14, 2019 0

12 3...8 Page 1 of 8